← Eichor
Study identifier: NCT07167316 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Role of the LC-NA System in Experimental Sleep Fragmentation

Condition: The Role of the LC-NA System in Sleep Regulation  ·  Sponsor: Hans-Peter Landolt

PhasePhase 1
Planned participants42
Who can joinAll sexes, 18 Years to 35 Years
Healthy volunteersYes

About this study

Sleep-wake regulation affects every person's life, yet the molecular mechanisms underlying these processes remain poorly understood. In particular, the microstructure of sleep has not been sufficiently studied to explain how sleep produces a feeling of restoration the following morning. Stress also plays a significant role in sleep regulation. This study aims to investigate the role of norepinephrine in these processes.

This description comes directly from the study's public registry record.

Talk to the study team

Rafael Wespi, PhD  ·  +41 44 635 59 61  ·  rafael.wespi@pharma.uzh.ch

Always discuss trial participation with your own doctor first.

Locations (1)

University of Zurich, Institute of Pharmacology and ToxicologyZurich, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07167316